Top news stories related to diabetes and kidney disease in 2024
Click Here to Manage Email Alerts
Healio has compiled a list of the most-read nephrology news stories related to diabetes and metabolic dysfunction in 2024.
Readers were most interested in kidney effects of diabetes medications and new guidance for diabetes, cardiorenal and metabolic diseases from Heart in Diabetes CME Conference.
Semaglutide slowed progression of CKD, cut cardiovascular events, mortality risk
Use of semaglutide by adults with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo. Read more.
SGLT2 inhibitors may delay kidney complications better than other anti-diabetes agents
In a real-world study, SGLT2 inhibitors and glucagon-like peptide-1 receptor agonists were more effective than dipeptidyl peptidase-4 inhibitors and sulfonylureas in reducing kidney complications for adults with type 2 diabetes and moderate cardiovascular risk. Read more.
Tirzepatide linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s
Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data. Read more.
Kidney function decline slows in patients with diabetes on empagliflozin vs. placebo
Patients with type 2 diabetes and chronic kidney disease receiving empagliflozin were less likely to experience a decline in eGFR compared with patients taking placebo, study results show. Read more.
New prognostic test may help improve hypertension in patients with diabetic kidney disease
Acetazolamide may reduce GFR without impacting glucose metabolism in type 1 diabetes
Acetazolamide was associated with an acute, reversible drop in GFR without impacting glucose metabolism for adults with type 1 diabetes and preserved kidney function, according to study data. Read more.
Long-term albuminuria risks among Asian American adults with diabetes differ by ethnicity
Long-term albuminuria risks for U.S. adults with Asian/Pacific Islander ancestry who have diabetes and normal kidney function differ across ethnic subgroups, according to data. Read more.
VIDEO: Heart in Diabetes unveils new guidance for diabetes, cardiorenal and metabolic diseases
In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, presents updated multispecialty practice recommendations for diabetes, cardiorenal and metabolic diseases at the Heart in Diabetes CME Conference. Read more.
Collapse
Healio Coverage
Click Here to Manage Email Alerts